| Optical Studios | |
| 11855 Ulysses St Ne, Ste 140, Blaine, Minnesota 55434 | |
| (763) 592-8400 |
| Name | Optical Studios |
|---|---|
| Organization Name | North Suburban Optical |
| Location | 11855 Ulysses St Ne, Ste 140, Blaine, Minnesota 55434 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (763) 592-8400 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Cerus Corporation announced today that it has initiated patient enrollment in two European Phase III clinical trials for the INTERCEPT System for red blood cells.
The European Collaborative Oncological Gen-‐Environmental Study (COGS) project, whose main goal is to decipher the complex genetic bases of breast, prostate and ovarian cancers, publishes a total of 12 research articles in several prestigious journals, including Nature Genetics, Nature Communications, The American Journal of Human Genetics and PLOS Genetics.
Finding innovative, minimally invasive ways to treat liver cancer-and being able to tailor that treatment individually to patients-are hallmarks of interventional radiologists. Advances in yttrium-90 (Y-90) radioembolization for liver cancer, a leading cause of cancer deaths worldwide, are reported in studies in the October Journal of Vascular and Interventional Radiology.
An experimental malaria vaccine protected a small number of healthy, malaria-naïve adults in the United States from infection for more than one year after immunization, according to results from a Phase 1 trial described in the May 9th issue of Nature Medicine.
› Verified 4 days ago
| NPI Number | 1306042817 |
| Organization Name | NORTH SUBURBAN OPTICAL |
| Doing Business As | OPTICAL STUDIOS |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 11855 Ulysses St, Suite 140, Blaine, MN 55434 |
| Phone Number | 763-421-7420 |
News Archive
Cerus Corporation announced today that it has initiated patient enrollment in two European Phase III clinical trials for the INTERCEPT System for red blood cells.
The European Collaborative Oncological Gen-‐Environmental Study (COGS) project, whose main goal is to decipher the complex genetic bases of breast, prostate and ovarian cancers, publishes a total of 12 research articles in several prestigious journals, including Nature Genetics, Nature Communications, The American Journal of Human Genetics and PLOS Genetics.
Finding innovative, minimally invasive ways to treat liver cancer-and being able to tailor that treatment individually to patients-are hallmarks of interventional radiologists. Advances in yttrium-90 (Y-90) radioembolization for liver cancer, a leading cause of cancer deaths worldwide, are reported in studies in the October Journal of Vascular and Interventional Radiology.
An experimental malaria vaccine protected a small number of healthy, malaria-naïve adults in the United States from infection for more than one year after immunization, according to results from a Phase 1 trial described in the May 9th issue of Nature Medicine.
› Verified 4 days ago
News Archive
Cerus Corporation announced today that it has initiated patient enrollment in two European Phase III clinical trials for the INTERCEPT System for red blood cells.
The European Collaborative Oncological Gen-‐Environmental Study (COGS) project, whose main goal is to decipher the complex genetic bases of breast, prostate and ovarian cancers, publishes a total of 12 research articles in several prestigious journals, including Nature Genetics, Nature Communications, The American Journal of Human Genetics and PLOS Genetics.
Finding innovative, minimally invasive ways to treat liver cancer-and being able to tailor that treatment individually to patients-are hallmarks of interventional radiologists. Advances in yttrium-90 (Y-90) radioembolization for liver cancer, a leading cause of cancer deaths worldwide, are reported in studies in the October Journal of Vascular and Interventional Radiology.
An experimental malaria vaccine protected a small number of healthy, malaria-naïve adults in the United States from infection for more than one year after immunization, according to results from a Phase 1 trial described in the May 9th issue of Nature Medicine.
› Verified 4 days ago
Cvs Pharmacy #07152 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2357 108th Ln Ne, Blaine, Minnesota 55449 Phone: (763) 780-0776 | |
Cvs Pharmacy #16953 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1500 109th Ave Ne, Blaine, Minnesota 55449 Phone: (763) 354-1001 | |
Walgreens #5413 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 600 County Road 10 Ne, Blaine, Minnesota 55434 Phone: (763) 786-9081 | |
Walgreens #7781 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4202 Pheasant Ridge Dr Ne, Blaine, Minnesota 55449 Phone: (651) 255-1498 | |
Walgreens #7218 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 12480 Aberdeen St Ne, Blaine, Minnesota 55449 Phone: (763) 862-6596 |